Pulmonary veno-occlusive disease

Toggle: English / Spanish

Definition

Pulmonary veno-occlusive disease (PVOD) is a very rare disease. It leads to high blood pressure in the lung arteries (pulmonary hypertension).

Alternative Names

Pulmonary vaso-occlusive disease

Causes

In most cases, the cause of PVOD is unknown. The high blood pressure occurs in the pulmonary arteries. These lung arteries are directly connected to the right side of the heart.

The condition may be related to a viral infection. It may occur as a complication of certain diseases such as

, , or .

The disorder is most common among children and young adults. As the disease gets worse, it causes:

  • Narrowed pulmonary veins
  • Pulmonary artery hypertension
  • Congestion and swelling of the lungs

Exams and Tests

The health care provider will examine you and ask about your medical history and symptoms.

The exam may reveal:

Your provider may hear abnormal heart sounds when listening to the chest and lungs with a stethoscope.

The following tests may be done:

Treatment

There is currently no known effective medical treatment. However, the following medicines may be helpful for some people:

  • Medicines that widen the blood vessels (vasodilators)
  • Medicines that control the immune system response (such as azathioprine or steroids)

A lung transplant may be needed.

Outlook (Prognosis)

The outcome is often very poor in infants, with a survival rate of just a few weeks. Survival in adults may be months to a few years.

Possible Complications

Complications of PVOD may include:

When to Contact a Medical Professional

Call your provider if you have symptoms of this disorder.

References

Chin K, Channick RN. Pulmonary hypertension. In: Broaddus VC, Mason RJ, Ernst JD, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 6th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 58.

Huertas A, Girerd B, Dorfmuller P, O'Callaghan D, Humbert M, Montani D. Pulmonary veno-occlusive disease: advances in clinical management and treatments. Expert Rev Respir Med. 2011;5(2):217-229. PMID: 21510732. www.ncbi.nlm.nih.gov/pubmed/21510732.

Version Info

  • Last reviewed on 5/20/2016
  • Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch)

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2013 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.